| Literature DB >> 33846664 |
Hao Luo1, Lexuan Zhong1.
Abstract
The rapid increase in global cases of COVID-19 illness and death requires the implementation of appropriate and efficient engineering controls to improve indoor air quality. This paper focuses on the use of the ultraviolet germicidal irradiation (UVGI) air purification technology in HVAC ducts, which is particularly applicable to buildings where fully shutting down air recirculation is not feasible. Given the poor understanding of the in-duct UVGI system regarding its working mechanisms, designs, and applications, this review has the following key research objectives:•Identifying the critical parameters for designing a UVGI system, including the characterization of lamp output, behavior of the target microbial UV dose-response, and evaluation of the inactivation performance and energy consumption.•Elucidating the effects of environmental factors (air velocity, air temperature, and humidity) on the UVGI system design parameters and optimization of the in-duct UVGI design.•Summarizing existing UVGI system designs in the literature and illustrating their germicidal and energy performance in light of COVID-19 mitigation.Entities:
Keywords: Airborne microorganism disinfection; Environmental conditions; HVAC; SARS-CoV-2; UV rate constant; Ultraviolet germicidal irradiation (UVGI)
Year: 2021 PMID: 33846664 PMCID: PMC8021448 DOI: 10.1016/j.buildenv.2021.107852
Source DB: PubMed Journal: Build Environ ISSN: 0360-1323 Impact factor: 6.456
Fig. 1Predicted lamp surface temperature and convective heat loss ratio r for (a) mixed convection (U = 0.31 m/s) with lamp type 1; (b) forced convection (U = 2.5 m/s) with lamp type 1; (c) forced convection (U = 3 m/s) with lamp type 2.
Fig. 2Predicted lamp surface temperature and lamp output using r method (a) Study 3 [25] mixed convection (b) Study 3 [25] forced convection (c) Study 2 [24] forced convection.
UV rate constants for coronavirus.
| Phase | Coronavirus type | Paper | k (m2/J) | D90 (J/m2) |
|---|---|---|---|---|
| Liquid well plate | SARS-CoV-2 | [ | 0.0611 | 37.7 |
| [ | 0.0025 | 921.1 | ||
| [ | 0.0188 | 122.5 | ||
| [ | 0.0370 | 62.2 | ||
| SARS-CoV | [ | 0.0181 | 127.3 | |
| [ | 0.0575 | 40.1 | ||
| [ | 0.0008 | 2878.3 | ||
| [ | 0.0002 | 11599.9 | ||
| [ | 0.0111 (no soiling agent) | 207.5 (no soiling agent) | ||
| 0.0091 (Mucin) | 253.1 (Mucin) | |||
| 0.0099 (Sebum) | 232.6 (Sebum) | |||
| [ | 0.0093 | 247.6 | ||
| MERS-CoV | [ | 0.0094 | 244.9 | |
| [ | 0.0104 (no soiling agent) | 221.4 (no soiling agent) | ||
| 0.0089 (Mucin) | 258.8 (Mucin) | |||
| 0.0093 (Sebum) | 247.6 (Sebum) | |||
| MHV coronavirus | [ | 0.0266 (MHV 2) | 86.7 | |
| 0.0190 (MHV N) | 121.0 | |||
| [ | 0.0224 | 102.8 | ||
| Aerosol | Human Coronavirus | [ | 0.41 (HCoV-229E) | 5.6 (HCoV-229E) |
| 0.59 (HCoV-OC43) | 3.9 (HCoV-OC43) | |||
| MHV coronavirus | [ | 0.377 | 6.1 |
In-duct UVGI system designs in literature and the estimated coronavirus inactivation efficiencies.
| Design details | Reported inactivation efficiency in literature | Estimated inactivation efficiency (log reduction) in this study | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Design No. | Duct size W × H × L (m × m × m) | Lamp arrangement (lamp numbers, direction) | Power (W) | UV dose (J/m2) | Airflow (m/s) | Environmental conditions | ||||
| SARS-CoV-2 | SARS-CoV | |||||||||
| #1 (EPA 600/R-06/049) [ | 0.61 × 0.61 × 4.6 | 12 | 720 | 76.51 | 2.5 | 23.2–24.1 °C | MS2 | 98% | ~100% | ~100% (13.10) |
| #2 (EPA 600/R-06/050) [ | 1, perpendicular | 58 | 2.47 | 22.7–22.9 °C | 39% | 70.61% (0.53) | 62.23% (0.42) | |||
| #3 (EPA 600/R-06/051) [ | 4, perpendicular | 100 | 2.95 | 23–23.2 °C | 46% | 76.84% (0.64) | 68.74% (0.51) | |||
| #4 (EPA 600/R-06/052) [ | 6, perpendicular | 420 | 198.26 | 25.3–25.8 °C | 99% | ~100% (42.69) | ~100% (33.94) | |||
| #5 (EPA 600/R-06/053) [ | 5, parallel | 1100 | 164.39 | 24.4–24.8 °C | 99% | ~100% (35.40) | ~100% (28.14) | |||
| #6 (EPA 600/R-06/054) [ | 4, perpendicular | 240 | 5.82 | 23–23.2 °C | 75% | 94.42% (1.25) | 89.92% (0.99) | |||
| #7 (EPA 600/R-06/084) [ | 0.3 × 0.3 × 4.6 | 6, parallel, reflective | 750 | 423.42 | 1.56 | 21.2–24.1 °C | 100% | ~100% (91.17) | ~100% (72.49) | |
| #8 (EPA 600/R-06/085) [ | 0.61 × 0.61 × 4.6 | 12, pulsed, perpendicular | 7020 | 4.47 | 2.72 | 23.6–25.2 °C | 59% | 89.10% (0.96) | 82.83% (0.77) | |
| #9 [ | 0.2 × 0.2 × 1.4 | 1, perpendicular | 9 | 7.35 | 3 | 23 °C, 55% | SM (99.925%); PA (99.909%); EC (98.168%); SE1 (93.607%); SE2 (92.935%) | 97.39% (1.58) | 94.48% (1.26) | |
| #10 [ | 4.90 | 4.5 | – | 91.19% (1.06) | 85.51% (0.84) | |||||
| #11 [ | 3.68 | 6 | – | 83.83% (0.79) | 76.51% (0.63) | |||||
| #12 [ | 0.2 × 0.2 × 1.4 | 1, perpendicular | 9 | 6.52 | 3 | 20 °C, 50% | SE2 (81.73%); PA (99.75%); EC (95.92%) | 96.05% (1.40) | 92.35% (1.12) | |
| #13 [ | 3.91 | 5 | – | 85.62% (0.84) | 78.61% (0.67) | |||||
| #14 [ | 3.01 | 6.5 | – | 77.52% (0.65) | 69.47% (0.52) | |||||
| #15 [ | 0.61 × 0.61 × 2.74 | 4, perpendicular | 240 | 66.87 | 2 | 20 °C | – | ~100% (14.40) | ~100% (11.45) | |
| #16 [ | 44.58 | 3 | 10 °C | – | ~100% (9.60) | ~100% (7.63) | ||||
| #17 [ | 133.74 | 1 | 30 °C | – | ~100% (28.80) | ~100% (22.90) | ||||
| #18 [ | 4, parallel | 55.11 | 2 | 20 °C | – | ~100% (11.87) | ~100% (9.43) | |||
| #19 [ | 36.74 | 3 | 10 °C | – | ~100% (7.91) | ~100% (6.29) | ||||
| #20 [ | 110.21 | 1 | 30 °C | – | ~100% (23.73) | ~100% (18.87) | ||||
| #21 [ | 0.64 × 0.64 × 2.44 | 4, parallel | 240 | 6.30 | 0.93 | 22.7 °C; 31% | MS2 (99.21%); BB (99.94%); FH (43.77%); CD (96.84%) | 95.60% (1.36) | 91.65% (1.08) | |
| #22 [ | 0.61 × 0.61 × 3.54 | 1, perpendicular | 145 | 13.41 | 1.27 | 24 °C, 50% | SM (99%); SE (81%); | 99.87% (2.89) | 99.49% (2.30) | |
| #23 [ | 3, perpendicular | 435 | 31.97 | BS (50.5%); AV (10.5%); PC (0.5%); CS (9.5%) | ~100% (6.88) | ~100% (5.47) | ||||
| #24 [ | 6, perpendicular | 870 | 75.09 | BS (85%); AV (74.5%); PC (13.5%); CS (16%) | ~100% (16.17) | ~100% (12.86) | ||||
SM: S.marcescens; PA: P.alcaligenes; SE1: S.enterrica; SE2: S.epidermidis; EC: E.coli; BB: B.broncbiseptica; FH: feline herpesvirus-1; CD: canine distemper virus; BS: Bacillus subtilis; AV: Aspergillus versicolor; PC: Penicillum chrysogenum; CS: Cladosporium sphaerospermum.
Duct length estimated by ASHRAE standard 52.2 [69].
Lamp arrangement details in Ref. [29].
Lamp arrangement details in Ref. [32].
For inactivation efficiency greater than 99.995%, we present “~100%“.
In-duct UVGI system design suggestions from the literature data.
| Paper | Duct size W × H × L (m × m × m) | Lamp arrangement (lamp numbers, direction) | Average UV dose (standard deviation) (J/m2) | Conclusions | |
|---|---|---|---|---|---|
| [ | 0.61 × 0.61 × 2.74 | 4, perpendicular | 53.19–6479.66 | 1. Without considering the thermal effect on the lamp output, placing UV lamps in a crossflow gives higher UV irradiance. | |
| 4, parallel | 121.30–3732.26 | 2. Considering the wind chill effects, arranging lamps in parallel flow provides a higher average irradiance for a system with lower temperature and higher airflow. | |||
| [ | 0.61 × 0.61 × 1.83 | 1, perpendicular, 6 locations in the duct | 7.87–9.51 | 1. Placing the UV lamp at the duct center (height and length) provides the best average UV dose. | |
| 2. Lamp locates at the beginning of the duct performs better than locates at the end of the duct. | |||||
| 1, center of the duct, perpendicular | 10.97 (4.39) | 3. Lamp locates parallel to the airflow provides higher average UV dose. | |||
| 4. Higher standard deviation of the UV dose is observed for parallel scenario, indicating some particles receive a considerably lower UV dose than the average of the system. | |||||
| 3 lamps, perpendicular (arrangements see | 28.33 (10.06) | 5. The best performance is achieved by locating all three lamps at the center of the duct and distributed across the height of the duct. | |||
| 6. The more even the UV dose distribution is, the more efficient the system is. | |||||
| 7. Increasing the lamp numbers increases the UV dose distribution uniformity and indicates better energy usage. | |||||
| [ | 0.61 × 0.61 × 1.83 | 4, perpendicular | 18.3 (4.17) | 1. UV dose distribution non-uniformity (UV dose standard deviation) increases when changing the lamp array configuration from vertical to horizontal. | |
| 4, 30° perpendicular | 18.49 (4.60) | ||||
| 4, 60° perpendicular | 19.12 (6.75) | ||||
| 4, parallel | 18.39 (7.89) | ||||
| [ | 0.02 × 0.02 × 0.12 | 48 LEDs (at the floor and ceiling of the duct) | – | 1. The use of highly reflective surfaces significantly increases microbial inactivation and minimizes the impact of LED positions on inactivation levels. | |
| 72 LEDs (at the floor and ceiling of the duct) | |||||
Sensitivity analysis of the lamp power input with respect to the influence of air temperature, air velocity and relative humidity.
| City | T (°C) | U (m/s) | RH | Total-order index (confidence level) | ||
|---|---|---|---|---|---|---|
| T | U | RH | ||||
| 9.68–10.45 | 1.50–1.89 | 0.57–0.67 | 0.0599 (6.16 × 10−4) | 0.9016 (7.51 × 10−3) | 0.0398 (3.99 × 10−4) | |
| 10.06–10.62 | 1.55–1.91 | 0.73–0.77 | 0.0382 (4.21 × 10−4) | 0.9566 (7.54 × 10−3) | 0.0058 (5.82 × 10−5) | |
| 10.17–10.46 | 1.71–1.90 | 0.56–0.71 | 0.0291 (3.31 × 10−4) | 0.6614 (5.68 × 10−3) | 0.3101 (3.36 × 10−3) | |
Fig. 3Direct effect of air temperature, air velocity and relative humidity on the monthly energy consumption variation ratios across three climate zones.
Fig. 4Comparison of monthly energy consumption variation ratios between the original and humidity amended UV rate constant.
Design and energy consumption predictions of in-duct UVGI systems in literature for 99% SARS-CoV-2 inactivation (required UV dose: 11.17 J/m2 for summer and 6.29 J/m2 for winter).
| Original design (from EPA reports) | New design suggestions | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Design details | UV dose (J/m2) | Inactivation efficiency (log reduction) | Design | UV dose | Inactivation efficiency (log reduction) | Energy consumption (kW h) | |||
| Summer | Winter | Year | |||||||
| #1 (EPA 600/R-06/049) | 12 lamps (each 60W), reflective duct material | 76.51 | ~100% | 2 lamps | 12.75 | 99.50% (2.30) (summer) | 525.6 | 525.6 | |
| ~100% (24.19) (winter) | 99.99% (4.03) (winter) | ||||||||
| #2 (EPA 600/R-06/050) [ | 1 lamp (58W), perpendicular | 2.47 | 65.25% (0.45) (summer) | 5 lamps (summer) | 12.14 (summer) | 99.36% (2.19) (summer) | 1270.2 | 762.12 | |
| 76.38% (0.78) (winter) | 3 lamps (winter) | 7.49 (winter) | 99.57% (2.37) (winter) | ||||||
| #3 (EPA 600/R-06/051) [ | 4 lamps (each 25W), perpendicular | 2.95 | 71.70% (0.53) (summer) | 15 lamps (summer) | 11.30 (summer) | 99.09% (2.04) (summer) | 1462.5 | 985.5 | |
| #4 (EPA 600/R-06/052) [ | 6 lamps (each 70W), perpendicular, reflective | 198.26 | ~100% (35.80) (summer) | 1 lamp | 33.70 (summer) | ~100% (6.09) (summer) | 306.6 | 306.6 | |
| #5 (EPA 600/R-06/053) | 5 lamps (each 220W), parallel | 164.39 | ~100% (29.69) (summer) | 1 lamp | 32.88 | ~100% (5.94) (summer) | 963.6 | 963.6 | |
| #6 (EPA 600/R-06/054) [ | 4 lamps (each 60W), perpendicular | 5.82 | 91.71% (1.05) (summer) | 8 lamps (summer) | 11.48 (summer) | 99.15% (2.07) (summer) | 2102.4 | 1314 | |
| #7 (EPA 600/R-06/084) | 6 lamps (each 125W), parallel, reflective | 423.42 | ~100% (76.46) (summer) | 1 lamp | 70.57 | ~100% (12.74) (summer) | 547.5 | 547.5 | |
| #8 (EPA 600/R-06/085) | 12 pulsed lamps (each 585W), perpendicular | 4.47 | 85.23% (0.81) (summer) | 30 lamps (summer) | 11.18 (summer) | 99.01% (2.00) (summer) | 76,869 | 43559.1 | |
| 17 lamps (winter) | 6.33 (winter) | 99.00% (2.00) (winter) | |||||||
The UV dose for 99% inactivation is not corrected by the lamp output for summer and winter weather due to the lack of a heat transfer model for other lamp airflow facing scenarios.
Summer and winter UV doses are different due to the consideration of different lamp output for summer and winter HVAC operating conditions (050, 051, 054, 085: cylinder lamp forced convection).
For inactivation efficiency greater than 99.995%, we present “~100%“.
Fig. 5Schematic diagram of the UV dose calculation in ventilation ducts.